ArthroCare Company Profile (NASDAQ:ARTC)

About ArthroCare (NASDAQ:ARTC)

ArthroCare logoArthroCare Corporation (ArthroCare) is a medical device company. ArthroCare develops and manufactures surgical devices, instruments, and implants. Its devices enable surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its Coblation technology. This technology dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology, including its OPUS line of fixation products, as well as re-usable surgical instruments. ArthroCare's two core product consists of sports medicine and ear, nose, and throat (ENT), as well as other areas, such as spine, wound care, urology and gynecology. It's Sports Medicine, ENT and other products are marketed and sold through two principal geographic distribution channels: Americas (North and South America) and International (all other geographies). In May 2014, Smith & Nephew PLC acquired the Company.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Health Care Equipment & Supplies
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:ARTC
  • CUSIP: 04313610
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $3.00
  • 200 Day Moving Avg: $4.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 30.57
  • P/E Growth: 0
  • Dividend Yield: 1.0%

Frequently Asked Questions for ArthroCare (NASDAQ:ARTC)

What is ArthroCare's stock symbol?

ArthroCare trades on the NASDAQ under the ticker symbol "ARTC."

Who are some of ArthroCare's key competitors?

How do I buy ArthroCare stock?

Shares of ArthroCare can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ArthroCare's stock price today?

One share of ArthroCare stock can currently be purchased for approximately $48.60.

MarketBeat Community Rating for ArthroCare (NASDAQ ARTC)
Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  78 (Vote Outperform)
Underperform Votes:  69 (Vote Underperform)
Total Votes:  147
MarketBeat's community ratings are surveys of what our community members think about ArthroCare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for ArthroCare (NASDAQ:ARTC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for ArthroCare (NASDAQ:ARTC)
Price Target History for ArthroCare (NASDAQ:ARTC)
Analysts' Ratings History for ArthroCare (NASDAQ:ARTC)
No equities research coverage for this company has been tracked by


Earnings History for ArthroCare (NASDAQ:ARTC)
Earnings by Quarter for ArthroCare (NASDAQ:ARTC)
Earnings History by Quarter for ArthroCare (NASDAQ ARTC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2014Q313$0.35$0.32$96.00 million$96.06 millionViewN/AView Earnings Details
2/13/2014Q213$0.40$0.30$100.53 million$101.70 millionViewN/AView Earnings Details
8/5/2013Q2 2013$0.34($0.27)$93.67 million$92.10 millionViewListenView Earnings Details
5/7/2013Q1 2013$0.37$0.30$94.41 million$92.30 millionViewListenView Earnings Details
2/13/2013Q4 2012$0.37$0.30$93.78 million$96.90 millionViewListenView Earnings Details
10/31/2012$0.28$0.27ViewN/AView Earnings Details
8/1/2012$0.37$0.34ViewN/AView Earnings Details
5/2/2012$0.34$0.36ViewN/AView Earnings Details
2/16/2012$0.41($1.06)ViewN/AView Earnings Details
11/2/2011$0.30$0.05ViewN/AView Earnings Details
8/3/2011$0.35$0.34ViewN/AView Earnings Details
5/2/2011$0.30$0.36ViewN/AView Earnings Details
2/14/2011$0.28$0.30ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for ArthroCare (NASDAQ:ARTC)
Current Year EPS Consensus Estimate: $1.51 EPS
Next Year EPS Consensus Estimate: $1.59 EPS


Dividend History for ArthroCare (NASDAQ:ARTC)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for ArthroCare (NASDAQ:ARTC)
Insider Trades by Quarter for ArthroCare (NASDAQ:ARTC)
Insider Trades by Quarter for ArthroCare (NASDAQ:ARTC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/9/2014Jean WoloszkoSVPSell32,627$45.67$1,490,075.09View SEC Filing  
1/8/2014Barbara BoyanDirectorSell10,000$45.00$450,000.00View SEC Filing  
1/8/2014Bruce ProthroSVPSell33,478$45.82$1,533,961.96View SEC Filing  
1/6/2014Bruce ProthroSVPSell6,167$39.75$245,138.25View SEC Filing  
12/19/2013Barbara BoyanDirectorSell10,000$40.00$400,000.00View SEC Filing  
12/19/2013Jean WoloszkoSVPSell10,657$39.98$426,066.86View SEC Filing  
10/30/2013Jean WoloszkoSVPSell1,342$37.95$50,928.90View SEC Filing  
10/7/2013James PacekSVPSell2,500$34.48$86,200.00View SEC Filing  
6/18/2013Bruce ProthroSVPSell2,512$36.00$90,432.00View SEC Filing  
5/24/2013Peter WilsonDirectorSell10,000$33.36$333,600.00View SEC Filing  
11/13/2012David FitzgeraldDirectorSell25,000$31.34$783,500.00View SEC Filing  
8/7/2012James G FosterDirectorSell35,000$28.81$1,008,350.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for ArthroCare (NASDAQ:ARTC)
Latest Headlines for ArthroCare (NASDAQ:ARTC)
No headlines for this company have been tracked by



ArthroCare (ARTC) Chart for Wednesday, October, 18, 2017

This page was last updated on 10/18/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.